The purpose of this document is to update the 2021 ECDP with further data from recent studies and to provide succinct, practical guidance for managing patients ...

8 мая 2024 г. · The 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy provides recommendations to guide clinicians.

25 авг. 2023 г. · The aim of this ESC guideline is to help health professionals manage people with heart failure (HF) according to the best available evidence.

28 мая 2024 г. · The 2023 ESC focused update of the 2021 HF guidelines introduced new key recommendations based on the results of the last years of science.

8 авг. 2024 г. · 2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized with Heart Failure Focused Update

8 авг. 2024 г. · This document describes performance measures for heart failure that are appropriate for public reporting or pay-for-performance programs.

28 мая 2024 г. · Second, SGLT2 inhibitors are now recommended for the treatment of HF across the entire left ventricular ejection fraction spectrum. The benefits ...

16 апр. 2024 г. · A review comparing contemporary clinical practice recommendations for the management of heart failure (HF) in the American and European guidelines.

14 мая 2024 г. · Patients with an LVEF of 40% or less: Use an ACEI to prevent symptomatic HF and lower mortality; or use beta blockers to prevent symptomatic HF.

This review serves to compare contemporary clinical practice recommendations for the management of heart failure (HF), as codified in the 2021 European Society ...